Skip to main content
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
20.54
+0.35 (1.73%)
At close: Mar 10, 2026

SHE:301246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 2020 - 2016
Market Capitalization
8,1505,38510,392---
Upgrade
Market Cap Growth
47.64%-48.18%----
Upgrade
Enterprise Value
7,4334,0688,758---
Upgrade
Last Close Price
20.5413.5025.83---
Upgrade
PE Ratio
573.06104.64119.22---
Upgrade
PS Ratio
4.623.045.06---
Upgrade
PB Ratio
1.881.242.38---
Upgrade
P/TBV Ratio
1.961.292.49---
Upgrade
P/OCF Ratio
--294.81---
Upgrade
EV/Sales Ratio
4.212.304.26---
Upgrade
EV/EBITDA Ratio
38.1219.1039.79---
Upgrade
EV/EBIT Ratio
-115.30136.98---
Upgrade
Debt / Equity Ratio
0.150.090.080.210.050.13
Upgrade
Debt / EBITDA Ratio
3.331.751.581.240.180.37
Upgrade
Debt / FCF Ratio
-----1.85
Upgrade
Net Debt / Equity Ratio
-0.17-0.38-0.42-0.02-0.02-0.09
Upgrade
Net Debt / EBITDA Ratio
-3.70-7.75-8.32-0.15-0.09-0.26
Upgrade
Net Debt / FCF Ratio
2.159.384.170.180.66-1.28
Upgrade
Asset Turnover
0.300.310.430.650.750.77
Upgrade
Inventory Turnover
6.026.886.674.402.892.57
Upgrade
Quick Ratio
1.972.353.200.931.011.15
Upgrade
Current Ratio
2.912.683.501.261.671.87
Upgrade
Return on Equity (ROE)
0.31%1.18%2.69%22.93%34.51%24.35%
Upgrade
Return on Assets (ROA)
0.00%0.38%0.84%5.18%10.62%13.04%
Upgrade
Return on Invested Capital (ROIC)
0.01%1.16%2.46%12.86%23.80%28.10%
Upgrade
Return on Capital Employed (ROCE)
0.00%0.80%1.40%10.20%19.60%28.10%
Upgrade
Earnings Yield
0.17%0.96%0.84%---
Upgrade
FCF Yield
-4.11%-3.27%-4.23%---
Upgrade
Dividend Yield
0.15%0.22%0.19%---
Upgrade
Payout Ratio
179.39%59.97%61.72%3.44%0.45%3.40%
Upgrade
Buyback Yield / Dilution
1.24%-2.71%-10.02%0.00%-0.13%0.12%
Upgrade
Total Shareholder Return
1.39%-2.49%-9.83%0.00%-0.13%0.12%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.